Archive of entries posted by David Hunkar

On The Relative Size Of Emerging Markets To Developed Markets

Posted by on

Emerging equity markets are small in size relative to the market capitalization of developed markets. Emerging markets accounted for just over 12% of global market capitalization. Click to enlarge Source: The Curious Case for Emerging Markets by Philip Huber at bpsandpieces From an opportunity standpoint, the emerging universe is huge with over 6,000 stocks in the 24 …

Continue reading ‘On The Relative Size Of Emerging Markets To Developed Markets’ »

The Emotional Cycle of Investors

Posted by on

Investing in the equity markets is hard and is even harder to become successful at it. One of the main variables that affects investors’ performance is emotion. Keeping emotions under control and being calm when markets are rough is easier said than done. However investors who are able to withstand severe corrections and bear markets, …

Continue reading ‘The Emotional Cycle of Investors’ »

Which Emerging Markets Are Vulnerable To Higher Oil Prices: Chart

Posted by on

Brent crude for December 2018 delivery closed at over $84 on Friday. Oil prices have soared in the past year and continue to power higher. Supply issues in Venezuela and Iran are also adding further pressure on oil prices. U.S. sanctions on Iran will take effect on November 5, 3018 which will have more impact …

Continue reading ‘Which Emerging Markets Are Vulnerable To Higher Oil Prices: Chart’ »

Gold Returns in Various Currencies 2001 Thru 2017

Posted by on

Gold prices are down so far this year. However gold as an asset class has returned positive returns in various currencies from 2001 thru 2017. The performance of gold in various currencies is shown in the table below: Click to enlarge Source: IGWTreport, Incrementum The average annual performance of gold between 2001 and 2017 was …

Continue reading ‘Gold Returns in Various Currencies 2001 Thru 2017’ »

The S&P Biotechnology Select Industry Index Returns: Chart

Posted by on

The S&P Biotechnology Select Industry Index is one of the major indices that tracks the biotech sector. The index is up just 8% YTD while the NYSE Arca Biotechnology Index has shot up over 23%. Click to enlarge Source: S&P Indices Overall Biotech stocks have performed so far well this year. Investors interested in the sector …

Continue reading ‘The S&P Biotechnology Select Industry Index Returns: Chart’ »